Polymorphism and epitope sharing between the alleles of merozoite surface protein-1 of Plasmodium falciparum among Indian isolates
Open Access
- 20 July 2007
- journal article
- Published by Springer Nature in Malaria Journal
- Vol. 6 (1) , 1-7
- https://doi.org/10.1186/1475-2875-6-95
Abstract
Background: The C-terminal region of merozoite surface protein-1 (MSP-1) is one of the leading candidates for vaccination against the erythrocytic stages of malaria. However, a major concern in the development of MSP-1 based malaria vaccine is the polymorphism observed in different geographicalPlasmodium falciparumisolates. To explore whether the sequence heterogeneity of PfMSP-1 leads to variation in naturally acquired anti-MSP-119antibodies, the present study was undertaken to study PfMSP-119sequence polymorphism in malaria-endemic villages in eastern India and also carried out a competition enzyme-linked immunosorbent assay using three PfMSP-119variant forms.Methods: The sequence variations in the C-terminal region of PfMSP-119were determined in a malaria endemic region. Three PfMSP-119variants were produced inEscherichia coli(PfMSP119QKNG-L, PfMSP119EKNG-L and PfMSP119ETSR-F) and an immunodepletion assay was carried out using the corresponding patients' sera.Results: Results revealed predominance of PfMAD20 allele among Indian field isolates. Seven PfMSP-119variant forms were isolated in a singe geographical location. Three of PfMSP-119variant forms when expressed inE. colishowed presence of cross-reaction as well as variant specific antibodies in malaria infected patient sera.Conclusion: The present study demonstrates the existence of allele specific antibodies inP. falciparum-infected patient sera, however their role in protection requires further investigation. These results thereby, suggest the importance of a multi-allelic PfMSP-119based vaccine for an effective malaria control.Keywords
This publication has 31 references indexed in Scilit:
- Immunity to RecombinantPlasmodium falciparumMerozoite Surface Protein 1 (MSP1): Protection inAotus nancymaiMonkeys Strongly Correlates with Anti-MSP1 Antibody Titer and In Vitro Parasite-Inhibitory ActivityInfection and Immunity, 2006
- Immunogenicity and protective efficacy of Escherichia coli expressed Plasmodium falciparum merozoite surface protein-142 using human compatible adjuvantsVaccine, 2006
- Comparison of Immunogenicities of RecombinantPlasmodium vivaxMerozoite Surface Protein 1 19- and 42-Kilodalton Fragments Expressed inEscherichia coliInfection and Immunity, 2004
- Progress and challenges for malaria vaccinesNature, 2002
- The economic and social burden of malariaNature, 2002
- Towards a blood-stage vaccine for malaria: are we following all the leads?Nature Reviews Immunology, 2001
- PCR and strain identification in Plasmodium falciparumParasitology Today, 1993
- Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1)Molecular and Biochemical Parasitology, 1993
- Merozoite surface antigen-I of plasmodiumParasitology Today, 1993
- Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparumJournal of Molecular Biology, 1987